Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution

Science
L J BeamerD Eisenberg

Abstract

Bactericidal/permeability-increasing protein (BPI), a potent antimicrobial protein of 456 residues, binds to and neutralizes lipopolysaccharides from the outer membrane of Gram-negative bacteria. At a resolution of 2.4 angstroms, the crystal structure of human BPI shows a boomerang-shaped molecule formed by two similar domains. Two apolar pockets on the concave surface of the boomerang each bind a molecule of phosphatidylcholine, primarily by interacting with their acyl chains; this suggests that the pockets may also bind the acyl chains of lipopolysaccharide. As a model for the related plasma lipid transfer proteins, BPI illuminates a mechanism of lipid transfer for this protein family.

References

Mar 5, 1992·Nature·R LüthyD Eisenberg
Jan 1, 1990·Annual Review of Biochemistry·C R Raetz
Jul 1, 1990·Acta Crystallographica. Section A, Foundations of Crystallography·A T BrüngerJ W Erickson
May 25, 1990·Nucleic Acids Research·S R Leong, T Camerato
Sep 21, 1990·Science·R R SchumannR J Ulevitch
Aug 20, 1986·Journal of Molecular Biology·Y SatowD R Davies
Sep 25, 1983·Journal of Molecular Biology·D H OhlendorfB W Matthews
Jul 28, 1995·The Journal of Biological Chemistry·A H TaylorJ Ghrayeb
Jan 1, 1995·Annual Review of Biochemistry·A Tall
Jan 1, 1994·Advances in Protein Chemistry·L BanaszakT A Jones
Sep 1, 1993·Protein Science : a Publication of the Protein Society·C Colovos, T O Yeates
Oct 1, 1995·Protein Engineering·D FischerH Wolfson
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4

❮ Previous
Next ❯

Citations

May 6, 1998·Protein Science : a Publication of the Protein Society·L J BeamerD Eisenberg
Jul 31, 1998·Protein Science : a Publication of the Protein Society·L J BeamerD Eisenberg
Dec 31, 2003·Developmental and Comparative Immunology·Jørgen StenvikTrond Ø Jørgensen T
Apr 27, 2004·Trends in Immunology·Colin D Bingle, C Jeremy Craven
Mar 20, 2001·Atherosclerosis·J HuuskonenC Ehnholm
Apr 8, 1999·Progress in Lipid Research·A Jonas
May 26, 1999·Infectious Disease Clinics of North America·J Hellman, H S Warren
Apr 2, 1998·Current Opinion in Immunology·I A Wilson, P J Bjorkman
Feb 27, 1999·Current Opinion in Immunology·R J Ulevitch, P S Tobias
Mar 6, 1999·Current Opinion in Microbiology·R P Darveau
Dec 9, 2000·Biochimica Et Biophysica Acta·S YamashitaY Matsuzawa
Dec 7, 2013·Experimental & Molecular Medicine·Beom Seok Park, Jie-Oh Lee
Jun 23, 2010·Immunology and Cell Biology·Horng-Der ShenWayne R Thomas
Jan 24, 2007·Nature Structural & Molecular Biology·Xiayang QiuAndrew P Seddon
Feb 15, 2001·The Biochemical Journal·A W GriffioenK H Mayo
Feb 22, 2002·European Journal of Biochemistry·Brian F TackRobert I Lehrer
May 21, 1999·European Journal of Biochemistry·G OlleschU Ermler
Jan 1, 2008·Molecular Simulation·Matthew B TessierRobert J Woods
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L HornJ B Zabriskie
Oct 21, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony M Barcia, Hobart W Harris
Jun 30, 1998·Current Opinion in Lipidology·L LagrostP Gambert
Jul 6, 2000·Current Opinion in Lipidology·J Huuskonen, C Ehnholm
May 29, 2004·Current Opinion in Lipidology·John J Albers, Marian C Cheung
May 9, 2006·Current Opinion in Lipidology·Xian-Cheng Jiang, Hong-Wen Zhou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.